Immuno Oncology Assays Market Worth $7.9 Billion by 2026 - Rising Incidence of Cancer and Growing Adoption of Targeted Therapies
According to the new market research report "Immuno Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics) - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5%.
View full press release